IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $293,000 | -86.0% | 15,117 | -87.9% | 0.00% | -80.0% |
Q4 2017 | $2,087,000 | -25.9% | 125,363 | -9.7% | 0.01% | -28.6% |
Q3 2017 | $2,818,000 | +4.5% | 138,764 | -17.1% | 0.01% | 0.0% |
Q2 2017 | $2,696,000 | +17.3% | 167,468 | -7.9% | 0.01% | +16.7% |
Q1 2017 | $2,299,000 | +18.9% | 181,779 | +24.6% | 0.01% | 0.0% |
Q4 2016 | $1,934,000 | -42.4% | 145,928 | +2.9% | 0.01% | -40.0% |
Q3 2016 | $3,360,000 | -12.7% | 141,784 | +6.2% | 0.01% | -16.7% |
Q2 2016 | $3,848,000 | -9.5% | 133,531 | +0.6% | 0.01% | -7.7% |
Q1 2016 | $4,250,000 | -43.4% | 132,730 | -24.4% | 0.01% | -40.9% |
Q4 2015 | $7,507,000 | -7.9% | 175,557 | -24.2% | 0.02% | -12.0% |
Q3 2015 | $8,155,000 | +14.2% | 231,601 | +48.9% | 0.02% | +38.9% |
Q2 2015 | $7,140,000 | +48.7% | 155,490 | +51.8% | 0.02% | +63.6% |
Q1 2015 | $4,801,000 | +571.5% | 102,442 | +353.8% | 0.01% | +450.0% |
Q4 2014 | $715,000 | -96.6% | 22,573 | -96.8% | 0.00% | -96.2% |
Q2 2014 | $21,032,000 | +7575.9% | 701,300 | +6649.1% | 0.05% | +5200.0% |
Q1 2014 | $274,000 | -19.6% | 10,391 | -23.3% | 0.00% | 0.0% |
Q4 2013 | $341,000 | -62.7% | 13,553 | -69.6% | 0.00% | -66.7% |
Q3 2013 | $914,000 | +19.3% | 44,574 | +16.1% | 0.00% | 0.0% |
Q2 2013 | $766,000 | – | 38,406 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |